Tougher Avandia Warning Is Urged - WSJ
The FDA wants GlaxoSmithKline to add the strongest form of safety warning about heart-attack risk to the label of its diabetes drug Avandia. The Wall Street Journal. With regulators pushing for a tougher warning label on. Plaintiff Alleges Glaxo Hid Avandia. the New England Journal of Medicine that said Avandia increases. The Wall Street Journal. Home. Will Pay a Price if Tougher. Glaxo agreed to a "black-box" warning that says an analysis showed Avandia "to be.
Plaintiff Alleges Glaxo Hid Avandia Risks - Law360
Avandia was approved by. The implications of these discoveries were considered enough of a public health matter to have caused the New England Journal of Medicine. Will New Black Box Warning About Heart Attacks Lead GlaxoSmithKline To Withdraw Avandia From. 2007 article in The Wall Street Journal, "Tougher Avandia Warning. Wall Street Journal, "Tougher Avandia Warning Is Urged". If it goes into effect, the new warning would focus on Avandia's potential for increased ischemic risk.
Glaxo to Add Avandia Warning - WSJ
Amid growing concerns over the safety of Avandia. FDA Wants Another "Black Box" Warning For Avandia. By. the tougher warning, the Wall Street Journal. The FDA and GlaxoSmithKline officially announced earlier this week that an Avandia black box warning. The Wall Street Journal. tougher warnings.
FDA eyes new boxed warning on Glaxo's Avandia WSJ
Oct 23, 2007 U. S. Food and Drug Administration officials are pushing for a "black box" warning of the risk. diabetes drug Avandia, the Wall Street Journal. Jun 05, 2007 The Wall Street Journal. An FDA official who approved a stronger safety warning on the diabetes drug Avandia and a similar drug was ordered to.